Refine by
Drug Manufacturing Articles & Analysis
60 news found
Following regulatory approval, Advanced Instruments, a wholly-owned subsidiary within Patricia Industries, has now completed its acquisition of Nova Biomedical, a global provider of analytical instruments and consumables for the biopharmaceutical and clinical markets. The enterprise value amounts to USD 2.2bn. Patricia Industries has contributed USD 1.6bn in financing. The remainder of the ...
Key Product Highlights: · PEG Derivatives o A vast inventory of over 3000 high-quality PEG derivatives. o Monodispersed PEG linkers and multi-arm PEGs. o Scalable production from R&D to GMP commercial levels. o Applications spanning ADCs, PROTACs, LNP drug delivery, medical devices, and more. · Pharmaceutical Intermediates o Comprehensive process development ...
Patricia Industries’ subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, today announced the execution of a definitive agreement to acquire Nova Biomedical, a manufacturer of innovative analytical instruments and consumables that are vital in guiding the treatment of patients and the ...
“Whether customers are trying to develop a new drug or seeking to improve the release characteristics of an existing drug, our lyophilization and flash-release technology are there to help,” said Protheragen-ING’s Chief Scientist. ...
By joining forces with DCAT, Protheragen-ING, a supplier of Vitamin C Products, API Products, Pharmaceutical Excipients, Packaging & Equipment, Veterinary Products, aims to contribute to the advancement of drug development and manufacturing. The Significance of DCAT DCAT is a non-profit and member-supported global business development association. ...
In the ever-evolving field of pharmaceutical research, the hunt for effective drugs often rests on the ability to understand and manipulate the solid-state properties of compounds. ...
CD Formulation, a leading CRO specialized in pharmaceutical formulation, has launched a new prescription screening process analysis service for both existing and new customers across the globe. The goal is to provide drug manufacturers with accurate and reliable results. Moreover, the technology used in this process is capable of detecting impurities and other ...
BOC Sciences, a leading CRO in the USA, unveils its comprehensive capabilities for custom peptide drug conjugate from project design to commercial production. With its well-established conjugation platform, BOC Sciences supports pharmaceutical and biotechnology clients at the forefront of drug conjugation. ...
In the wake of the COVID-19 pandemic, BOC Sciences, the world's reputed chemical supplier, declares that it will increase production to offer pharmaceutical impurity standards in bulk to satisfy unmet demands. Innovations in manufacturing processes, more complicated formulations, and increasingly complex global supply chains are just some of the factors making it more difficult ...
The companies will join forces to provide ‘end-to-end’ Contract Development Manufacturing Organization (CDMO) services to their clients, from pharmaceutical cell line development to large-scale contract manufacturing. EXCELLGENE will provide clients with services such as cell line generation and development of high-yielding processes, while LOTTE ...
“These additional resources will support our recently launched commercial services which, for the first time, will provide the pharmaceutical and biobanking industries with access to our proprietary metabolic database, as well as to our advanced interpretive software to assist in various phases of drug research, development, and manufacturing,” said ...
Company with a clear goal: To simplify protein production and accelerate the delivery of drugs to patients. Revolutionizing Biopharma manufacturing LenioBio develops efficient and sustainable technologies for protein expression. Company with a clear goal: To simplify protein production and accelerate the delivery of drugs to patients. emberto ...
Nasaldrugdeliveryblog.com opens lines of communication between drug delivery researchers, device manufacturers. The first blog to address issues related to nasal drug delivery formulation, research, delivery, and devices was launched by Kurve Technology, Inc., a leading developer of nasal drug delivery devices. ...
This preventative approach will allow Lumen to develop an inexpensive, biologic drug cocktail against the most frequent, multi-drug resistant infecting pathogens. ...
The Company intends to use the net proceeds from the offering to continue pipeline development of its pharmaceutical drug candidates, advance manufacturing know-how of cannabinoids and cannabinoid analogs, support intellectual property development and other commercial activities, and for general working capital purposes. ...
The Company intends to use the net proceeds from the offering to continue pipeline development of its pharmaceutical drug candidates, advance manufacturing know-how of cannabinoids and cannabinoid analogs, support intellectual property development and other commercial activities, and for general working capital purposes. ...
Known for its competence, responsibility, and innovative capability in chemical supply, Alfa Chemistry recently unveiled its new role as a CDMO service provider for pharmaceutical companies worldwide. Contract Development and Manufacturing Organization, abbreviated as CDMO, is a preferential way for a majority of pharmaceutical companies to outsource ongoing drug ...
Scandinavian Biopharma continues to strengthen its organization in manufacturing and is pleased to welcome Anna Sumic as our new DS & DP Manufacturing Specialist. Anna has a Master of Science in Chemistry and Chemical Engineering from KTH, Royal Institute of Technology, with 15 years of experience within the pharmaceutical industry. She is joining us from AFRY, a consulting company, where ...
XPhyto’s Rotigotine transdermal product is a single product based on its 100% owned platform technology which represents a scalable opportunity for additional TDS drug development and manufacturing programs. According to Research and Markets, the global transdermal skin patch market had a value of nearly US$6.5 billion in 2020 while Kuick Research, ...
The award, stage-gated based on achievement of pre-determined milestones and deliverables, provides funding for Enalare to perform pre-clinical toxicology, human clinical studies, drug and device manufacturing, and regulatory file submission for a formulation of ENA-001 suitable for community use. ...